Alzheimer Disease and Dementia

Latest News

First Diagnostic Agent Approved to Image Tau Pathology for Alzheimer Disease

The FDA has approved Tauvid for PET imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles.

Comorbid Visual Impairment, Dementia Heighten Disability Risk

Older adults with both dementia and self-reported visual impairment may be at higher risk for disability than adults with only one of these conditions.

Anti-TNF Agents May Lower Alzheimer Disease Risk for Patients With Psoriasis, Rheumatoid Arthritis

A subset of patients at risk for Alzheimer disease because of systemic inflammation may benefit from receiving a tumor necrosis factor blocking agent.

Relationship Between Serum Uric Acid and Cognitive Function, Dementia

Researchers explored the association between midlife serum uric acid and the risk for cognitive decline and dementia.

Early Metformin Initiation Does Not Appear to Reduce Risk for Dementia

Previous research has suggested that treatment with metformin may potentially lower the risk of dementia, however whether the timing of treatment impacts this result remains unclear.

Psoriasis Linked to Inreased Risk for Alzheimer Disease

The risk for AD among patients with psoriasis was significantly increased in psoriasis patients not receiving systemic therapy compared with those receiving systemic therapy.

Reviews Assess Tools to Identify, Diagnose, Treat Alzheimer Dementia

Many cognitive tests can differentiate clinical Alzheimer-type dementia from normal cognition.

Benzodiazepines, Z-Drugs Not Associated With Subsequent Dementia Risk

Use of benzodiazepines, Z-drugs, or other anxiolytics was not associated with incident dementia in either the cohort or nested case-control design.

Visual Impairment May Increase Risk for Dementia in Older Women

In older women, objectively measured visual impairment is associated with a twofold to more than fivefold increased risk for dementia.

KL-VSHET+ Genotype Linked to Reduced Alzheimer Disease Risk

the gene variant may be protective in those aged 60 to 80 years, cognitively normal, who carry APOE4.